# Intercept Pharmaceuticals, Inc. – FDA Inspection, Apr 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/intercept-pharmaceuticals-inc/3a3ba5e7-11c8-4c49-8ecc-4b9fc08ccad1
Source feed: FDA_Inspections

> FDA inspection 1236571 of Intercept Pharmaceuticals, Inc., April 22, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1236571
- Company Name: Intercept Pharmaceuticals, Inc.
- Inspection Date: 2024-04-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1257609 - 2024-11-14

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jay-b-shah/c437fff9-807e-4dea-80c0-8f77850db6f8)
- [Company Rep](https://www.keypedia.com/people/tyanna-n-hadley/8fdebfd7-d6f3-44ab-9dcb-864ab6d55d53)

Company: https://www.keypedia.com/companies/intercept-pharmaceuticals-inc/a2d7de0c-c1b2-4078-a084-cc07cd0b86a8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c